Search Results

You are looking at 1 - 10 of 130 items for :

  • "proteomics" x
Clear All
Free access

Robert Lee Stanley, Takako Ohashi, Jacob Gordon and Chishimba Nathan Mowa

to identify the signature proteins and their potential roles during the first 48 h of postpartum using the proteomics analysis. Materials and methods Animals and postpartum time intervals Pregnant wild-type mice (C57BL6/129SvEv; Charles

Open access

Kamran Ullah, Tanzil Ur Rahman, Hai-Tao Pan, Meng-Xi Guo, Xin-Yan Dong, Juan Liu, Lu-Yang Jin, Yi Cheng, Zhang-Hong Ke, Jun Ren, Xian-Hua Lin, Xiao-Xiao Qiu, Ting-Ting Wang, He-Feng Huang and Jian-Zhong Sheng

. 2015 ). Proteomic analysis of the human receptive vs non-receptive endometrium showed differential proteomic repertoire during the window of implantation ( Dominguez et al . 2009 ). However, the impact of high E 2 levels to predict IVF outcome has

Free access

Xinran Hu, David Friedman, Salisha Hill, Richard Caprioli, Wendell Nicholson, Alvin C Powers, Lawrence Hunter and Lee E Limbird

wild type (WT) vs α 2A AR ‘knockout’ (KO) mice, and the regulation of glucose-stimulated insulin release (GSIS) by α 2 agonist. Secondly, we explored whether a proteomic strategy would successfully identify downstream signaling targets of the α 2A AR

Free access

I Paron, C D’Ambrosio, A Scaloni, M T Berlingieri, P L Pallante, A Fusco, N Bivi, G Tell and G Damante

differential proteomics approach, usually combining two-dimensional gel electrophoresis (2-D PAGE) and mass spectrometry analysis, is a well-established procedure ( Simpson & Dorow 2001 ). Compared with nucleic acids-based approaches, such as DNA microarrays or

Open access

Yanjun Cui and Xianhong Gu

, proteomics technologies facilitate the analysis of thousands of proteins, offering powerful tools for comprehensively assessing molecular alterations of intestines due to heat exposure. Molecular mechanisms underlying the effects of chronic HS in the

Free access

Biswapriya B Misra, Carl Langefeld, Michael Olivier and Laura A Cox

Introduction Access to large-scale omics datasets (genomics, tran­scriptomics, proteomics, metabolomics, metagenomics, phenomics, etc.) has revolutionized biology and led to the emergence of systems approaches to advance our understanding of

Free access

Arnaud Droit, Guy G Poirier and Joanna M Hunter

. Fortunately, proteomics (the study of the protein complement of the genome) offers opportunities to understand protein expression and protein function. While the genome is fixed, the proteome is much more dynamic. It changes during cellular development and in

Free access

A Stevens, C De Leonibus, D Hanson, A W Dowsey, A Whatmore, S Meyer, R P Donn, P Chatelain, I Banerjee, K E Cosgrove, P E Clayton and M J Dunne

techniques, including the ready availability of second- and third-generation sequencing platforms; associated methods (such as RNA-seq and ChIP-seq); other high-throughput ‘omics methods, including quantitative proteomics, interactomics and miRNAomics

Free access

Karen Oliva, Gillian Barker, Clyde Riley, Mark J Bailey, Michael Permezel, Gregory E Rice and Martha Lappas

.8 4.01 ANXA5, ATPB, BASP1, FTL, heterogeneous nuclear ribonucleoprotein C (HNRPC), and VIME were all ≥1.5-fold higher in lean patients. On the other hand, A1AT and GRP75 were ≥1.5-fold higher in obese patients. Validation of proteomic results by qRT

Free access

Evan Simpson and Anna Spada

Dear Readers, Having served as Editor-in-Chief of Journal of Molecular Endocrinology for seven years, I would like to take this opportunity to thank all those who have contributed to the journal's success – the Editorial Board, authors and referees.

Following a great increase in the journal's impact factor in the early part of my term of office, submissions to the journal began to increase significantly, approaching a remarkable 250% of what they had been previously. This gave us the opportunity to build upon the journal's established reputation by improving its high quality standards even further. One of the ways of achieving this was to increase the rejection rate. Prior to 2000, the acceptance rate of the journal had typically been around 60% for many years. In recent years, this percentage has often been in the thirties. Despite this, the number of papers published in a year has frequently been more than it was historically, and rapid growth from one year to the next has sometimes had the effect of temporarily decreasing the journal's impact factor compared with the heights we had previously achieved, because of the way it is calculated. We have also increased the journal's online frequency to monthly, ensuring that the journal is poised ready for the rapid publication of greater numbers of higher quality papers.

With this legacy, I am pleased to hand over the reins of the journal to Professor Anna Spada, and I wish her well in taking the journal to new heights.

As the incoming Editor-in-Chief of the Journal of Molecular Endocrinology, I feel proud to be associated with a major international journal dedicated to publishing excellent science in the field of molecular endocrinology. Together with the new members of the Editorial Board, we are committed to continue the tradition of excellence established by our predecessors. We would like to take this opportunity to thank the outgoing Editor-in-Chief, Professor Evan Simpson, who contributed greatly to the development and prestige of the journal during his tenure. We would also like to acknowledge with gratitude the efforts of all the other members of the Editorial Board who are retiring.

As we enter the year 2008, the journal begins its 20th year of serving the global endocrine community as a vital forum for research on molecular endocrinology. Moreover, the journal recently became an official journal of the European Society of Endocrinology, a fact that confirms its increasing significance and importance. The journal has an active Editorial Board who represent both the global reach of the journal and the breadth of expertise needed to build upon its current subject coverage.

Journal of Molecular Endocrinology has undergone substantial developments recently, including full migration to an electronic manuscript handling system and monthly online publication, together with immediate publication of authors' accepted manuscripts. These changes, together with the hard work of the staff of the Society for Endocrinology, the journal's publisher, have had a major impact on the efficiency of manuscript handling, with rapid and careful decisions on submitted manuscripts. High-profile review articles are freely available to all on the web and the improved features of the new platform, including toll-free reference linking and ‘This article has been cited by…’ links to and from other major journals, have increased JME's online visibility.

We are committed to publishing the best endocrine research at the molecular level, and we believe that the journal has a particular role in integrating basic molecular mechanisms towards understanding the physiological and pathological processes of the endocrine system. We want to encourage the submission of manuscripts that expand our knowledge of the molecular mechanisms underlying hormone action; examples of potential topics include proteomics, structural features of RNA and the impact on mRNA regulation and processing, DNA repair mechanisms underlying endocrine disorders and cancers, DNA–protein complexes and chromatin structures and the accessibility of promoter–regulatory regions, molecular chaperones, etc. Articles on molecular endocrinology with potential translational/clinical significance, methodology and bioinformatics tools are especially welcome. We also want to attract papers from leaders in other fields who are investigating endocrine-related aspects but do not traditionally publish in our journal. A series of mini-reviews will address a wide range of provocative and updated topics that we believe will extend our range of interest and will aim to anticipate the future direction of many specific research areas. As many of the mini-reviews will be invited, we welcome suggestions of topics and authors as well as outlines of potential mini-reviews from interested authors.

It is with a good deal of humility that I take over the reins of the journal. It is my intention to ensure that it remains at the forefront of endocrine research and, along with the Editorial Board, we are hopeful that we can raise JME's standards even higher.